B-070 Supar: what UACR and GFR don't say von Valaperta, S, Gamba, S, Leo, C, Moioli, V, Saiaci, C, Marozzi, R, Alessio, M

Volltext

A-223 Direct LDL or not Direct-LDL, that is the question von Valaperta, S, Apassiti Esposito, S, Picciau, A, Moioli, V, Saiaci, C, Marozzi, R, Alessio, M

Volltext

A-224 Non HDL Cholesterol: could be e new cardiovascular disease risk stratification factor? von Valaperta, S, Apassiti Esposito, S, Moioli, V, Picciau, A, Saiaci, C, Marozzi, R, Alessio, M

Volltext

Suppression of tumorigenicity 2 (SST2) vs NT-PRO-BNP (PBNP) in cardiac allograft vasculopaty (CAV) monitoring after heart transplantation von Valaperta, S., Tagliabue, M., Iacovoni, A., Moioli, V., Saiaci, C., Ferlita, A., Alessio, M.G.

Volltext

Hemolysis (HI) ittero (II) (lipemia (LI) index testing: A quality daily challenge for the laboratory von Valaperta, S., Moioli, V., Saiaci, C., Maini, A., Ferlita, A., Alessio, M.G.

Volltext

Failure mode and effects analysis (FMEA) and preanalytical phase: Proactive risk menagment and process optimizazion von Sala, M., Parimbelli, M., Beluzzi, A., Valaperta, S., Saiaci, C., Marozzi, R., Moioli, V., Alessio, M.G.

Volltext